Medicine and Dentistry
Cystic Fibrosis
100%
Cystic Fibrosis Transmembrane Conductance Regulator
47%
Patient with Cystic Fibrosis
29%
Ivacaftor
27%
Tezacaftor
23%
Lumacaftor
21%
Management of Cystic Fibrosis
20%
Secretin
20%
Collecting Duct
18%
COVID-19
16%
Sodium Bicarbonate
16%
Patient-Reported Outcome
16%
Early Intervention
16%
Cohort Analysis
16%
Solid Organ Transplantation
16%
Pendrin
16%
Urinary System
14%
Secretion (Process)
13%
Metabolic Alkalosis
12%
Base
11%
Remote Sensing
10%
Consultation
10%
Disorders of Calcium Metabolism
7%
Health Care
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
66%
Dicarbonate
33%
Cystic Fibrosis Transmembrane Conductance Regulator
30%
Tezacaftor
23%
Ivacaftor
23%
Base
17%
Aciduria
16%
Secretin
14%
Disease
6%
Biological Marker
6%
Biochemistry, Genetics and Molecular Biology
Cystic Fibrosis
50%
Cystic Fibrosis Transmembrane Conductance Regulator
50%
Ivacaftor
18%
Secretion (Process)
16%
Base Excess
12%
Disorders of Calcium Metabolism
9%
Pendrin
6%
